|
1
|
Tang H, Tang Z, Jiang Y, Wei W and Lu J:
Pathological and therapeutic aspects of matrix metalloproteinases:
Implications in osteosarcoma. Asia Pac J Clin Oncol. 15:218–224.
2019.PubMed/NCBI
|
|
2
|
Limaiem F, Kuhn J and Khaddour K: Cancer,
Telangiectatic Osteosarcoma. StatPearls. StatPearls Publishing,
Treasure Island (FL). Online. 2019
|
|
3
|
Valery PC, Laversanne M and Bray F: Bone
cancer incidence by morphological subtype: A global assessment.
Cancer Causes Control. 26:1127–1139. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Roberts RD, Lizardo MM, Reed DR, Hingorani
P, Glover J, Allen-Rhoades W, Fan T, Khanna C, Sweet-Cordero EA,
Cash T, et al: Provocative questions in osteosarcoma basic and
translational biology: A report from the Children's oncology group.
Cancer. 25:3514–3525. 2019. View Article : Google Scholar
|
|
5
|
Bernthal NM, Federman N, Eilber FR, Nelson
SD, Eckardt JJ, Eilber FC and Tap WD: Long-term results (>25
years) of a randomized, prospective clinical trial evaluating
chemotherapy in patients with high-grade, operable osteosarcoma.
Cancer. 118:5888–5893. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Carina V, Costa V, Sartori M, Bellavia D,
De Luca A, Raimondi L, Fini M and Giavaresi G: Adjuvant biophysical
therapies in osteosarcoma. Cancers. 11:E3482019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Daw NC, Chou AJ, Jaffe N, Rao BN, Billups
CA, Rodriguez-Galindo C, Meyers PA and Huh WW: Recurrent
osteosarcoma with a single pulmonary metastasis: A
multi-institutional review. Br J Cancer. 112:278–282. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Isakoff MS, Bielack SS, Meltzer P and
Gorlick R: Osteosarcoma: Current treatment and a collaborative
pathway to success. J Clin Oncol. 33:3029–3035. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xie B, Li Y, Zhao R, Xu Y, Wu Y, Wang J,
Xia D, Han W and Chen D: Identification of key genes and miRNAs in
osteosarcoma patients with chemoresistance by bioinformatics
analysis. Biomed Res Int. 2018:47610642018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen XG, Ma L and Xu JX: Abnormal DNA
methylation may contribute to the progression of osteosarcoma. Mol
Med Rep. 17:193–199. 2018.PubMed/NCBI
|
|
11
|
Wang JS, Duan MY, Zhong YS, Li XD, Du SX,
Xie P, Zheng GZ and Han JM: Investigating ageinduced differentially
expressed genes and potential molecular mechanisms in osteosarcoma
based on integrated bioinformatics analysis. Mol Med Rep.
19:2729–2739. 2019.PubMed/NCBI
|
|
12
|
Tian H, Guan D and Li J: Identifying
osteosarcoma metastasis associated genes by weighted gene
co-expression network analysis (WGCNA). Medicine (Baltimore).
97:e107812018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang JS, Wang YG, Zhong YS, Li XD, Du SX,
Xie P, Zheng GZ and Han JM: Identification of co-expression modules
and pathways correlated with osteosarcoma and its metastasis. World
J Surg Oncol. 17:462019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Najafi M, Ahmadi A and Mortezaee K:
Extracellular-signal- regulated kinase/mitogen-activated protein
kinase signaling as a target for cancer therapy: An updated review.
Cell Biol Int. 43:1206–1222. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Papa S, Choy PM and Bubici C: The ERK and
JNK pathways in the regulation of metabolic reprogramming.
Oncogene. 38:2223–2240. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Abe MK, Saelzler MP, Espinosa R III, Kahle
KT, Hershenson MB, Le Beau MM and Rosner MR: ERK8, a new member of
the mitogen-activated protein kinase family. J Biol Chem.
277:16733–16743. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lau ATY and Xu YM: Regulation of human
mitogen-activated protein kinase 15 (extracellular signal-regulated
kinase 7/8) and its functions: A recent update. J Cell Physiol.
234:75–88. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cargnello M and Roux PP: Activation and
function of the MAPKs and their substrates, the MAPK-activated
protein kinases. Microbiol Mol Biol Rev. 75:50–83. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jin DH, Lee J, Kim KM, Kim S, Kim DH and
Park J: Overexpression of MAPK15 in gastric cancer is associated
with copy number gain and contributes to the stability of c-Jun.
Oncotarget. 6:20190–20203. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rossi M, Colecchia D, Ilardi G, Acunzo M,
Nigita G, Sasdelli F, Celetti A, Strambi A, Staibano S, Croce CM
and Chiariello M: MAPK15 upregulation promotes cell proliferation
and prevents DNA damage in male germ cell tumors. Oncotarget.
7:20981–20998. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Z, Li N, Shen L and Fu J: Quantitative
proteomic analysis identifies MAPK15 as a potential regulator of
radioresistance in nasopharyngeal carcinoma cells. Front Oncol.
8:5482018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Scott MC, Temiz NA, Sarver AE, LaRue RS,
Rathe SK, Varshney J, Wolf NK, Moriarity BS, O'Brien TD, Spector
LG, et al: Comparative transcriptome analysis quantifies immune
cell transcript levels, metastatic progression, and survival in
osteosarcoma. Cancer Res. 78:326–337. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Robinson MD, McCarthy DJ and Smyth GK:
edgeR: A bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shimazui T, Yoshikawa K, Ishitsuka R,
Kojima T, Kandori S, Yoshino T, Miyazaki J, Uchida K and Nishiyama
H: Systemic transduction of p16(INK4a) antitumor peptide inhibits
lung metastasis of the MBT-2 bladder tumor cell line in mice. Oncol
Lett. 17:1203–1210. 2019.PubMed/NCBI
|
|
26
|
Meazza C and Scanagatta P: Metastatic
osteosarcoma: A challenging multidisciplinary treatment. Expert Rev
Anticancer Ther. 16:543–556. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Aljubran AH, Griffin A, Pintilie M and
Blackstein M: Osteosarcoma in adolescents and adults: Survival
analysis with and without lung metastases. Ann Oncol. 20:1136–1141.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Y, Yang J, Zhao N, Wang C, Kamar S,
Zhou Y, He Z, Yang J, Sun B, Shi X, et al: Progress in the
chemotherapeutic treatment of osteosarcoma. Oncol Lett.
16:6228–6237. 2018.PubMed/NCBI
|
|
29
|
Ahmed G, Zamzam M, Kamel A, Ahmed S,
Salama A, Zaki I, Kamal N and Elshafiey M: Effect of timing of
pulmonary metastasis occurrence on the outcome of metastasectomy in
osteosarcoma patients. J Pediatr Surg. 54:775–779. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Coulombe P and Meloche S: Atypical
mitogen-activated protein kinases: Structure, regulation and
functions. Biochim Biophys Acta. 1773:1376–1387. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu DD, Lau ATY, Yu FY, Cai NL, Dai LJ, Ok
Kim M, Jin DY and Xu YM: Extracellular signal-regulated kinase
8-mediated NF-KB activation increases sensitivity of human lung
cancer cells to arsenic trioxide. Oncotarget. 8:49144–49155.
2017.PubMed/NCBI
|
|
32
|
Xu YM, Zhu F, Cho YY, Carper A, Peng C,
Zheng D, Yao K, Lau AT, Zykova TA, Kim HG, et al: Extracellular
signal-regulated kinase 8-mediated c-Jun phosphorylation increases
tumorigenesis of human colon cancer. Cancer Res. 70:3218–3227.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shay G, Lynch CC and Fingleton B: Moving
targets: Emerging roles for MMPs in cancer progression and
metastasis. Matrix Biol 44–46. 200–206. 2015. View Article : Google Scholar
|
|
34
|
Merchant N, Nagaraju GP, Rajitha B,
Lammata S, Jella KK, Buchwald ZS, Lakka SS and Ali AN: Matrix
metalloproteinases: Their functional role in lung cancer.
Carcinogenesis. 38:766–780. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ge HX, Zou FM, Li Y, Liu AM and Tu M: JNK
pathway in osteoarthritis: Pathological and therapeutic aspects. J
Recept Signal Transduct Res. 37:431–436. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang F, Ke ZF, Wang R, Wang YF, Huang LL
and Wang LT: Astrocyte elevated gene-1 (AEG-1) promotes
osteosarcoma cell invasion through the JNK/c-Jun/MMP-2 pathway.
Biochem Biophys Res Commun. 452:933–939. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yu Y, Li Y, Zhou L, Yang G, Wang M and
Hong Y: Cryptochrome 2 (CRY2) suppresses proliferation and
migration and regulates clock gene network in osteosarcoma cells.
Med Sci Monit. 24:3856–3862. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jie Z, Xie Z, Zhao X, Sun X, Yu H, Pan X,
Shen S, Qin A, Fang X and Fan S: Glabridin inhibits osteosarcoma
migration and invasion via blocking the p38- and JNK-mediated
CREB-AP1 complexes formation. J Cell Physiol. 234:4167–4178. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cheng HL, Hsieh MJ, Yang JS, Lin CW, Lue
KH, Lu KH and Yang SF: Nobiletin inhibits human osteosarcoma cells
metastasis by blocking ERK and JNK-mediated MMPs expression.
Oncotarget. 7:35208–35223. 2016.PubMed/NCBI
|
